v3.26.1
Other Assets and Liabilities
 12 Months Ended
Mar. 31, 2026
Other Assets And Liabilities [Abstract]  
Other Assets and Liabilities OTHER ASSETS AND LIABILITIES
Major components of other assets and liabilities at March 31, 2025 and 2026 were as follows:
 20252026
 (in millions)
Other assets:   
Accounts receivable:  
Receivables from brokers, dealers and customers for securities transactions¥293,058 ¥760,323 
Other(1)
2,026,871 2,071,305 
Investments in equity method investees4,564,269 5,461,950 
Prepaid benefit cost (Note 13)2,196,632 2,639,445 
Cash collateral pledged for derivative transactions (Note 9)2,566,588 4,261,209 
Cash collateral for the use of Bank of Japan’s settlement infrastructure10,000 10,000 
Accrued interest761,358 864,973 
Deferred tax assets (Note 8)123,343 131,902 
Right-of-use assets of operating leases (Note 7)247,221 282,736 
Other(2)
6,344,058 9,279,436 
Total¥19,133,398 ¥25,763,279 
Other liabilities:
Accounts payable:
Payables to brokers, dealers and customers for securities transactions¥1,447,659 ¥1,596,728 
Other1,690,202 2,161,767 
Obligations to return securities received as collateral (Notes 15, 16 and 31)6,046,755 8,468,326 
Accrued interest560,982 583,981 
Deferred tax liabilities (Note 8)754,888 773,980 
Allowance for off-balance sheet credit instruments178,054 160,786 
Accrued benefit cost (Note 13)103,957 106,363 
Guarantees and indemnifications73,443 93,686 
Cash collateral received for derivative transactions (Note 9)1,415,939 1,417,988 
Obligations under operating leases (Note 7)341,499 370,365 
Accrued and other liabilities3,799,463 4,153,797 
Total¥16,412,841 ¥19,887,767 
Notes:
(1)Accounts receivable—Other is primarily comprised of receivables relating to the card business. The provision or reversal of the allowance for credit losses relating to the receivables is included in Non-interest expense on the consolidated statements of income. The credit quality for these receivables is primarily evaluated based on the extent of delinquency. The outstanding balance of these account receivables are presented on a net basis after allowance for credit losses. The change of allowance for credit losses during the fiscal years ended March 31, 2024, 2025 and 2026 is primarily due to provision or reversal of the allowance for the receivables.
(2)Other includes a contract to purchase equity shares of Shriram Finance Limited held by MUFG Bank. MUFG Bank measured the fair value of the investment agreement to acquire a 20.0% equity interest in Shriram Finance Limited (“SFL”) as of March 31, 2026, based on the difference between the agreed share purchase price and the market price as of March 31, 2026. As a result, MUFG Bank recognized ¥25,111 million of the contract in Other Assets. See Note 33 for further information.
Investments in equity method investees include marketable equity securities carried at ¥3,885,529 million and ¥4,708,181 million at March 31, 2025 and 2026, respectively. Corresponding aggregated market values were ¥7,461,707 million and ¥11,034,755 million at March 31, 2025 and 2026, respectively. Marketable equity securities include Morgan Stanley’s common stock carried at ¥3,247,891 million and ¥3,996,002 million at March 31, 2025 and 2026, respectively. As of March 31, 2026, the MUFG Group held approximately 23.87% of its common stock. Investments in equity method investees also include investments in Morgan Stanley MUFG Securities, Co., Ltd. at ¥195,614 million and ¥211,579 million at March 31, 2025 and 2026, respectively.
The MUFG Group periodically evaluates whether a loss in value of investments in equity method investees is other-than-temporary. As a result of evaluations, the MUFG Group recognized other-than-temporary declines in the value of an investment and recorded impairment losses related to certain affiliated companies of ¥19,978 million, ¥8,177 million and ¥6,546 million for the fiscal years ended March 31, 2024, 2025 and 2026, respectively. The impairment losses are included in Equity in earnings of equity method investees—net in the accompanying consolidated statements of income.
Summarized Financial Information of the MUFG Group’s Equity Method Investees
Summarized financial information of Morgan Stanley, the largest portion of the MUFG Group’s equity method investees, as of March 31, 2025 and 2026, and for each of the three years ended March 31, 2026 is as follows:
 20252026
 (in billions)
Trading assets¥59,844 ¥84,131 
Securities purchased under agreements to resell17,800 20,605 
Securities borrowed20,967 24,713 
Total assets194,420 252,837 
Deposits57,051 68,424 
Customer and other payables30,163 41,455 
Borrowings45,662 59,406 
Total liabilities178,295 234,390 
Noncontrolling interests155 176 
 202420252026
 (in billions)
Net revenues¥7,907 ¥9,739 ¥11,081 
Total non-interest expenses6,068 6,843 7,498 
Income from continuing operations before income taxes1,798 2,835 3,536 
Net income applicable to Morgan Stanley1,375 2,162 2,736 
Summarized financial information of the MUFG Group’s equity method investees, other than Morgan Stanley as of March 31, 2025 and 2026, and for each of the three years ended March 31, 2026 is as follows:
 20252026
 (in billions)
Net loans¥20,315 ¥21,992 
Total assets40,852 44,782 
Deposits13,742 15,644 
Total liabilities32,900 35,404 
Noncontrolling interests93 106 
 202420252026
 (in billions)
Total interest income¥1,820 ¥1,998 ¥2,052 
Total interest expense782 775 868 
Net interest income1,038 1,223 1,184 
Provision for credit losses291 366 252 
Income before income tax expense698 838 1,164 
Net income596 704 997